• Skip to main content
  • Skip to navigation
Site name
Site name
Mast navigation
  • Become a member
  • Sign In
Search our site
Menu
Close menu
  • Home
  • News
  • Oncology
  • AI
  • Topics
    • Back to parent navigation item
    • Topics
    • Technology
    • Resources
    • Diseases
    • Drugs and therapies
    • Research and development
    • Tools and techniques
    • Business
  • Webinars
  • Whitepapers
  • Reports
  • Home
  • News
  • Oncology
  • AI
  • Topics
      • Technology
      • Resources
      • Diseases
      • Drugs and therapies
      • Research and development
      • Tools and techniques
      • Business
    • AACR 2
      AACR 2026 part 1: AI design, precision biology and the next wave of oncology innovation
    • 16_Still01_Bo and Lexi looking at computer_cleaned
      When scale meets insight: reinventing SPR for the future of drug discovery
    • shutterstock_2530482803
      AI to antibody in days: breaking the wet lab bottleneck via high-throughput integration
  • Webinars
  • Whitepapers
  • Reports
  • More navigation items

Premium members qualification

  • No comments

Topics

  • Neurological disorders
  • No comments

Related articles

  • shutterstock_2579142623
    News

    Organoid study reveals valproate’s impact on developing brain

    2026-05-27T08:59:00Z

    By Drug Target Review

  • shutterstock_2084522077
    Article

    Beyond tangles: why soluble intracellular tau should guide drug discovery

    2026-05-27T07:00:00Z

    By Professor Marc Aurel Busche

  • shutterstock_2679304735
    News

    OutSee wins Longitude Prize award for ALS target discovery

    2026-05-19T12:00:00Z

    By Drug Target Review

  • shutterstock_2771790713
    Article

    Women in STEM: resilience and leadership in rare disease research

    2026-05-19T09:46:00Z

    Contributor Dr Nitza Thomasson

  • shutterstock_293692067
    News

    AI-designed viral vectors achieve 50-fold brain enrichment over AAV9

    2026-05-19T09:01:00Z

  • shutterstock_2567876707
    Article

    Turning CRISPR hits into confident drug discovery decisions

    2026-05-07T12:30:00Z

    By Dr Salman Tamaddon-Jahromi

No comments yet

You're not signed in.

Only registered users can comment on this article.

Sign in Register

Partner content

  • shutterstock_2771790713
    Article

    Women in STEM: resilience and leadership in rare disease research

    2026-05-19T09:46:00

    Contributor Dr Nitza Thomasson

  • Computer,Screen,With,Molecular,Modelling,Software,Simulating,Proteins,,Designing,New
    Webinar

    The truth about AI in drug discovery: what the experts really think

    2026-03-11T14:00:00

    Sponsored by Merck

  • CELLVO~1
    Webinar

    What it takes to automate high-content imaging at scale

    2026-03-25T15:00:00 2026-03-25T16:00:00

    Sponsored by Yokogawa

  • App note - Halo Labs
    Whitepaper

    Application note: Revolutionising drug formulations with polysorbate detection

    2023-03-30T09:15:30

    Sponsored by Halo Labs

  • Ruth 8 by 6
    Article

    Advanced techniques in toxicity testing

    2024-08-05T15:00:04

    Sponsored by Molecular Devices

  • Client Asset Template copy
    Whitepaper

    Executive summary: Scale-up strategies for late-stage cell therapies

    2023-01-06T16:37:30

    Sponsored by Catalent

  • Topics
  • Technology
  • Resources
  • Diseases
  • Drugs and therapies
  • Research and development
  • Tools and techniques
  • Business
  • Advertising & Editorial
  • Advertising opportunities
  • Media planner
  • Advertising tech specs
  • Information for authors
  • Reuse policy
  • Information
  • About us
  • Company information
  • Careers
  • Terms and conditions
  • Privacy policy
  • Cookie policy
The trusted voice in drug discovery
Find us on social media:
  • Topics A-Z
  • Writers A-Z
  • © 2026 Drug Target Review

Site powered by Webvision Cloud